Celltrion
068270.KS
#659
Rank
NZ$50.40 B
Marketcap
$243.37
Share price
3.23%
Change (1 day)
30.88%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

P/S ratio for Celltrion (068270.KS)

P/S ratio as of September 2024 (TTM): 15.8

According to Celltrion 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 15.7933. At the end of 2024 the company had a P/S ratio of 13.3.

P/S ratio history for Celltrion from 2008 to 2024

PS ratio at the end of each year

Year P/S ratio Change
202413.3-34.57%
202320.396.25%
202210.3-26.58%
202114.1-50.29%
202028.337.99%
201920.5-26.19%
201827.8-8.07%
201730.361.89%
201618.721.08%
201515.491.5%
20148.06-53.24%
201317.227.37%
201213.5-29.73%
201119.3-12.41%
201022.094.21%
200911.31.01%
200811.2